PRX, ALKS, Initiated At Buy

Loading...
Loading...
UBS has initiated coverage for the following companies: Par Pharmaceutical Companies
PRX
Buy, $35 price target Alkermes Inc.
ALKS
Buy, $18 price target
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsalkermesBiotechnologyHealth Carepar pharmaceuticalPharmaceuticalsUBS
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...